Close Menu

Over at In the Pipeline, Derek Lowe comments on the fact that slowly but surely, Merck has been getting many of the large Vioxx judgments against it overturned on appeal. Out of 20 that went to court, Merck has won 17. Part of the problem, says Lowe, is that the bad effects (heart attacks) happened to only a few people, compared to the total number who were taking the drug, many of whom didn't need it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.